# Low-dose Aspirin Therapy for Esophageal Cancer

> **NCT02326779** · PHASE3 · WITHDRAWN · sponsor: **Zhejiang University**

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** Acetylsalicylic acid

## Key facts

- **NCT ID:** NCT02326779
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-03
- **Primary completion:** 2018-10
- **Final completion:** 2018-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study could not be performed.
- **Last updated:** 2021-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02326779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02326779, "Low-dose Aspirin Therapy for Esophageal Cancer". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT02326779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*